Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

157 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Glucosuric, renal and haemodynamic effects of licogliflozin, a dual inhibitor of sodium-glucose co-transporter-1 and sodium-glucose co-transporter-2, in patients with chronic kidney disease: A randomized trial.
He Y, Pachori A, Chen P, Ma S, Mendonza AE, Amer A, Marbury TC, Hinder M. He Y, et al. Among authors: hinder m. Diabetes Obes Metab. 2021 May;23(5):1182-1190. doi: 10.1111/dom.14327. Epub 2021 Feb 16. Diabetes Obes Metab. 2021. PMID: 33512754 Clinical Trial.
LLF580, an FGF21 Analog, Reduces Triglycerides and Hepatic Fat in Obese Adults With Modest Hypertriglyceridemia.
Rader DJ, Maratos-Flier E, Nguyen A, Hom D, Ferriere M, Li Y, Kompa J, Martic M, Hinder M, Basson CT, Yowe D, Diener J, Goldfine AB; CLLF580X2102 Study Team. Rader DJ, et al. Among authors: hinder m. J Clin Endocrinol Metab. 2022 Jan 1;107(1):e57-e70. doi: 10.1210/clinem/dgab624. J Clin Endocrinol Metab. 2022. PMID: 34431493 Free PMC article. Clinical Trial.
Vascular effects of serelaxin in patients with stable coronary artery disease: a randomized placebo-controlled trial.
Corcoran D, Radjenovic A, Mordi IR, Nazir SA, Wilson SJ, Hinder M, Yates DP, Machineni S, Alcantara J, Prescott MF, Gugliotta B, Pang Y, Tzemos N, Semple SI, Newby DE, McCann GP, Squire I, Berry C. Corcoran D, et al. Among authors: hinder m. Cardiovasc Res. 2021 Jan 1;117(1):320-329. doi: 10.1093/cvr/cvz345. Cardiovasc Res. 2021. PMID: 32065620 Free PMC article. Clinical Trial.
A framework to guide dose & regimen strategy for clinical drug development.
Sander O, Magnusson B, Ludwig I, Jullion A, Meille C, Lorand D, Bornkamp B, Hinder M, Kovacs SJ, Looby M. Sander O, et al. Among authors: hinder m. CPT Pharmacometrics Syst Pharmacol. 2021 Nov;10(11):1276-1280. doi: 10.1002/psp4.12701. Epub 2021 Sep 25. CPT Pharmacometrics Syst Pharmacol. 2021. PMID: 34562310 Free PMC article.
157 results